Company
vTv Therapeutics
Committed to Improving the Lives of People with Diabetes
- Status
- Operatingas of 2026-09-18Source (opens in a new tab)
- vtvtherapeutics.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
vTv Therapeutics (vTv) is a late-stage biopharmaceutical company focused on developing oral, small molecule drug candidates intended to help treat people living with diabetes and other chronic diseases.
Funding snapshot
- Total raised
- $70.5MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $51M2024-02-27
Funding rounds
- Round, 2024
- $51M2024-02-27, SEC form D sold, 4 investors
- Round, 2020
- $2M2020-01-07, SEC form D sold
- Round, 2019
- $2M2019-09-27, SEC form D sold
- Round, 2019
- $4M2019-06-25, SEC form D sold
- Round, 2018
- $1.5M2018-12-27, SEC form D sold
- Round, 2018
- 2018-08-10
- Round, 2017
- $10M2017-12-05, SEC form D sold, 1 investor
Products
- Other
- cadisegliatin
Loading relationship preview